The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 17, 2011
Filed:
Sep. 02, 2009
Robert Plourde, Jr., Chapel Hill, NC (US);
Sammy R. Shaver, Chapel Hill, NC (US);
James G. Douglass, Iii, Apex, NC (US);
Paul S. Watson, Carrboro, NC (US);
José L. Boyer, Chapel Hill, NC (US);
Chi Tu, San Diego, CA (US);
Melwyn A. Abreo, Jamul, CA (US);
Lorenzo J. Alfaro-lopez, San Marcos, CA (US);
Yangbo Feng, Palm Beach Gardens, FL (US);
Daniel F. Harvey, San Diego, CA (US);
Tatyana V. Khasonova, San Diego, CA (US);
Robert Plourde, Jr., Chapel Hill, NC (US);
Sammy R. Shaver, Chapel Hill, NC (US);
James G. Douglass, III, Apex, NC (US);
Paul S. Watson, Carrboro, NC (US);
José L. Boyer, Chapel Hill, NC (US);
Chi Tu, San Diego, CA (US);
Melwyn A. Abreo, Jamul, CA (US);
Lorenzo J. Alfaro-Lopez, San Marcos, CA (US);
Yangbo Feng, Palm Beach Gardens, FL (US);
Daniel F. Harvey, San Diego, CA (US);
Tatyana V. Khasonova, San Diego, CA (US);
Inspire Pharmaceuticals, Inc., Durham, NC (US);
Abstract
This invention is directed to a method of preventing or treating diseases or conditions associated with platelet aggregation. The method is also directed to a method of treating thrombosis or related disorders. The method comprises administering to a subject a pharmaceutical composition comprising an effective amount of a non-nucleotide compound, preferably a P2Yreceptor antagonist compound, wherein said amount is effective to inhibit platelet aggregation. The compounds useful for this invention include compounds of general Formulae I and III-XII, or salts, hydrates, and solvates thereof. The present invention also provides novel compounds of Formulae I and III-XII.